Literature DB >> 9361014

The laminin alpha2-chain short arm mediates cell adhesion through both the alpha1beta1 and alpha2beta1 integrins.

H Colognato1, M MacCarrick, J J O'Rear, P D Yurchenco.   

Abstract

Laminin-2, a heterotrimer composed of alpha2, beta1, and gamma1 subunits, is the primary laminin isoform found in muscle and peripheral nerve and is essential for the development and stability of basement membranes in these tissues. Expression of a domain VI-truncated laminin alpha2-chain results in muscle degeneration and peripheral nerve dysmyelination in the dy2J dystrophic mouse. We have expressed amino-terminal domains VI through IVb of the laminin alpha2-chain, as well as its laminin-1 alpha1-chain counterpart, to identify candidate cell-interactive functions of this critical region. Using integrin-specific antibodies, recognition sites for the alpha1beta1 and alpha2beta1 integrins were identified in the short arms of both laminin alpha1- and alpha2-chain isoforms. Comparisons with a beta-alpha chimeric short arm protein possessing beta1-chain domain VI further localized these activities to alpha-chain domain VI. In addition, we found that the laminin alpha2-chain short arm supported neurite outgrowth independent of other laminin-2 subunits. A heparin/heparan sulfate binding activity was also localized to this region of the laminin alpha2 subunit. These data provide the first evidence that domain VI of the laminin alpha2-chain mediates interactions with cell surface receptors and suggest that these integrin and heparin binding sites, alone or in concert, may play an important role in muscle and peripheral nerve function.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9361014     DOI: 10.1074/jbc.272.46.29330

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  26 in total

1.  Complete sequence, recombinant analysis and binding to laminins and sulphated ligands of the N-terminal domains of laminin alpha3B and alpha5 chains.

Authors:  Jörg H O Garbe; Walter Göhring; Karlheinz Mann; Rupert Timpl; Takako Sasaki
Journal:  Biochem J       Date:  2002-02-15       Impact factor: 3.857

2.  Regulation of neurite outgrowth by integrin activation.

Authors:  J K Ivins; P D Yurchenco; A D Lander
Journal:  J Neurosci       Date:  2000-09-01       Impact factor: 6.167

Review 3.  The role of laminins in basement membrane function.

Authors:  M Aumailley; N Smyth
Journal:  J Anat       Date:  1998-07       Impact factor: 2.610

Review 4.  Basement membranes: cell scaffoldings and signaling platforms.

Authors:  Peter D Yurchenco
Journal:  Cold Spring Harb Perspect Biol       Date:  2011-02-01       Impact factor: 10.005

Review 5.  Laminin isoforms in endothelial and perivascular basement membranes.

Authors:  Lema F Yousif; Jacopo Di Russo; Lydia Sorokin
Journal:  Cell Adh Migr       Date:  2012-12-21       Impact factor: 3.405

Review 6.  The laminin family.

Authors:  Monique Aumailley
Journal:  Cell Adh Migr       Date:  2012-12-21       Impact factor: 3.405

7.  Neuronal receptors mediating responses to antibodyactivated laminin-1.

Authors:  J K Ivins; H Colognato; J A Kreidberg; P D Yurchenco; A D Lander
Journal:  J Neurosci       Date:  1998-12-01       Impact factor: 6.167

Review 8.  Developmental and pathogenic mechanisms of basement membrane assembly.

Authors:  Peter D Yurchenco; Bruce L Patton
Journal:  Curr Pharm Des       Date:  2009       Impact factor: 3.116

Review 9.  The role of laminins in the organization and function of neuromuscular junctions.

Authors:  Robert S Rogers; Hiroshi Nishimune
Journal:  Matrix Biol       Date:  2016-09-07       Impact factor: 11.583

10.  beta1 integrin maintains integrity of the embryonic neocortical stem cell niche.

Authors:  Karine Loulier; Justin D Lathia; Veronique Marthiens; Jenne Relucio; Mohamed R Mughal; Sung-Chun Tang; Turhan Coksaygan; Peter E Hall; Srinivasulu Chigurupati; Bruce Patton; Holly Colognato; Mahendra S Rao; Mark P Mattson; Tarik F Haydar; Charles Ffrench-Constant
Journal:  PLoS Biol       Date:  2009-08-18       Impact factor: 8.029

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.